CTNND1
protein-codingcatenin delta 1, the group of p120 catenin family|Armadillo repeat containing
Gene summary
This gene encodes a member of the Armadillo protein family, which function in adhesion between cells and signal transduction. Multiple translation initiation codons and alternative splicing result in many different isoforms being translated. Not all of the full-length natures of the described transcript variants have been determined. Read-through transcription also exists between this gene and the neighboring upstream thioredoxin-related transmembrane protein 2 (TMX2) gene. [provided by RefSeq, Dec 2010]
- CTNND
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~66.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0040503
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007339
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0040503
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0040503
Submitter: ClinGen
*CTNND1* was first reported in relation to autosomal dominant blepharocheilodontic syndrome (BCDS) in 2017 (Ghoumid et al.; PMID: 28301459). The phenotype of this disorder includes eye abnormalities, cleft lip/palate, and dental problems. 10 variants (frameshift, nonsense, missense) that have been reported in at least 15 probands in 3 publications (PMIDs: 28301459, 29348693, 32196547) are included in this curation. The maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be haploinsufficiency. This gene-disease relationship is also supported by experimental evidence (expression-level evidence, animal models; PMID: 32196547). Expression-level evidence in human embryos shows high and specific craniofacial expression. A mouse model and a xenopus model both recapitulate the human phenotype of craniofacial structural anomalies/abnormal expression in mutants. In summary, there is definitive evidence supporting the relationship between *CTNND1* and autosomal dominant BCDS. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date 3/21/2024 (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0040503
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dermatologic; Dental
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CTNND1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001085458.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 15 | 2 | 18 | ||
| missense | 1 | 3 | 195 | 16 | 4 | 219 |
| nonsense | 9 | 10 | 2 | 21 | ||
| start loss | 0 | |||||
| frameshift | 8 | 8 | 2 | 18 | ||
| splice donor/acceptor (+/-2bp) | 3 | 3 | 4 | 10 | ||
| Total | 21 | 24 | 204 | 31 | 6 | 286 |
Highest pathogenic variant AF is 0.0000013684253
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001078927.1 | 19 | MANE Select | |
| Ensembl | ENSP00000382004.5 | 19 | MANE Select | |
| RefSeq | NP_001078928.1 | 18 | Standard | |
| RefSeq | NP_001078929.1 | 17 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ctnnd1 | Danio rerio | Structure: post-vent region Quality: decreased length abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Adherens junction - Homo sapiens (human)
- Rap1 signaling pathway - Homo sapiens (human)
- Leukocyte transendothelial migration - Homo sapiens (human)
- VEGFA-VEGFR2 Signaling Pathway
- Wnt Signaling Pathway and Pluripotency
Biological Process
- cell-cell junction assembly
- cell adhesion
- brain development
- Wnt signaling pathway
- adherens junction organization
Molecular Function
- signaling receptor binding
- protein binding
- protein kinase binding
- cadherin binding
Cellular Component
- nucleus
- cytoplasm
- cytosol
- plasma membrane
- cell-cell junction
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000399050
- Coding exons
- 19
- Length
- 66304
- Individuals with no LoFs
- 124648
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 8
- Defined
- 124656
- p
- 0.0000321
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.08 | 432 | 572 | 0.756 | 0.0000352 | 6260 |
| Missense (PolyPhen) | 141 | 215.27 | 0.65498 | 2269 | ||
| Synonymous | 2.19 | 160 | 199 | 0.803 | 0.0000105 | 1913 |
| Loss of Function | 6.00 | 4 | 49.6 | 0.0806 | 0.00000277 | 588 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000057 | 0.000056 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000045 | 0.000044 | rare |
| South Asian | 0.000035 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Binds to and inhibits the transcriptional repressor ZBTB33, which may lead to activation of target genes of the Wnt signaling pathway (By similarity). Associates with and regulates the cell adhesion properties of both C-, E- and N-cadherins, being critical for their surface stability. Implicated both in cell transformation by SRC and in ligand-induced receptor signaling through the EGF, PDGF, CSF-1 and ERBB2 receptors. Promotes GLIS2 C-terminal cleavage. {ECO:0000250, ECO:0000269|PubMed:17344476, ECO:0000269|PubMed:20371349}.;
- Disease
- DISEASE: Blepharocheilodontic syndrome 2 (BCDS2) [MIM:617681]: A form of blepharocheilodontic syndrome, a rare autosomal dominant disorder. It is characterized by lower eyelid ectropion, upper eyelid distichiasis, euryblepharon, bilateral cleft lip and palate, and features of ectodermal dysplasia, including hair anomalies, conical teeth and tooth agenesis. An additional rare manifestation is imperforate anus. There is considerable phenotypic variability among affected individuals. {ECO:0000269|PubMed:28301459}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.272
Intolerance Scores
- LoFtool
- 0.538
- RVIS EVS
- -0.73
- RVIS percentile EVS
- 14.2
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.664
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |